Safety and Efficacy of Nabilone in Alzheimer's Disease

NCT02351882 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Agitation
Weight Loss
Pain
Oxidative Stress

Interventions

DRUG: Nabilone
DRUG: Placebo

Sponsor

Sunnybrook Health Sciences Centre